Used as an intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to form biaryl compounds. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in the development of active pharmaceutical ingredients (APIs). Commonly applied in the preparation of kinase inhibitors and other bioactive molecules in medicinal chemistry research. Also utilized in the synthesis of functionalized ethers for drug discovery and optimization.